HISTOCHEMICAL DISTRIBUTION OF CA-125 AS A PROGNOSTIC INDICATOR IN PATIENTS WITH SEROUS OVARIAN-CANCER

被引:3
作者
BICHEL, P
JAKOBSEN, A
ORNTOFT, TF
机构
[1] AARHUS UNIV, AARHUS KOMMUNE HOSP, INST PATHOL, DEPT CLIN CHEM, DK-8000 AARHUS, DENMARK
[2] VEJLE CENT HOSP, INST PATHOL, AARHUS, DENMARK
[3] DANISH CANC SOC, DEPT EXPTL CLIN ONCOL, AARHUS, DENMARK
关键词
CA-125; HISTOCHEMICAL DISTRIBUTION; OVARY CARCINOMA; PROGNOSIS;
D O I
10.1111/j.1525-1438.1991.tb00040.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study comprises 66 patients with stage Ill and IV serous ovarian carcinoma While the percentage of CA-125 positive cells and the staining intensity showed no correlation to patient survival, the pattern of CA-125 distribution, membranous versus cytoplasmic, was significantly correlated to survival. In accordance with other observations on switching of the antigen reaction f rom membrane to cytoplasm with increasing grade of atypia or malignancy, patients with membrane positive CA-125 tumors had a significantly better prognosis than did patients with CA-125 in the cytoplasm. Furthermore, there was excellent agreement between, on the one hand, the binding pattern of CA-125 and, on the other, the ploidy of the tumor cells and the HGI histopathologic grading index, both previously shown to be of prognostic significance.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 34 条
[1]  
BAAK JPA, 1986, ANAL QUANT CYTOL, V8, P354
[2]   MORPHOMETRIC DATA TO FIGO STAGE AND HISTOLOGICAL TYPE AND GRADE FOR PROGNOSIS OF OVARIAN-TUMORS [J].
BAAK, JPA ;
WISSEBREKELMANS, ECM ;
LANGLEY, FA ;
TALERMAN, A ;
DELEMARRE, JFM .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (12) :1340-1346
[3]  
BAAK JPA, 1986, ANAL QUANT CYTOL, V8, P349
[4]   THE PROGNOSTIC VARIABILITY OF OVARIAN TUMOR GRADING BY DIFFERENT PATHOLOGISTS [J].
BAAK, JPA ;
LANGLEY, FA ;
TALERMAN, A ;
DELEMARRE, JFM .
GYNECOLOGIC ONCOLOGY, 1987, 27 (02) :166-172
[5]  
BARBER HRK, 1975, AM J OBSTET GYNECOL, V121, P795
[6]   A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].
BAST, RC ;
KLUG, TL ;
STJOHN, E ;
JENISON, E ;
NILOFF, JM ;
LAZARUS, H ;
BERKOWITZ, RS ;
LEAVITT, T ;
GRIFFITHS, CT ;
PARKER, L ;
ZURAWSKI, VR ;
KNAPP, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887
[7]   REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA [J].
BAST, RC ;
FEENEY, M ;
LAZARUS, H ;
NADLER, LM ;
COLVIN, RB ;
KNAPP, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1331-1337
[8]   A RANDOMIZED STUDY OF CYCLOPHOSPHAMIDE AND CISPLATINUM WITH OR WITHOUT DOXORUBICIN IN ADVANCED OVARIAN-CARCINOMA [J].
BERTELSEN, K ;
JAKOBSEN, A ;
ANDERSEN, JE ;
AHRONS, S ;
PEDERSEN, PH ;
KIAER, H ;
ARFFMANN, E ;
BICHEL, P ;
BOESTOFTE, E ;
CHRISTOPHERSEN, IS ;
GREGERSEN, E ;
HANSEN, MK ;
HOLUND, B ;
JACOBSEN, M ;
JENSEN, HK ;
JEPSEN, FL ;
LARSEN, G ;
NIELSEN, ES ;
NYLAND, M ;
OLSEN, J ;
PANDURO, J ;
RANK, F ;
SELL, A ;
SOGAARD, H .
GYNECOLOGIC ONCOLOGY, 1987, 28 (02) :161-169
[9]   A NEW HISTOLOGIC GRADING INDEX IN OVARIAN-CARCINOMA [J].
BICHEL, P ;
JAKOBSEN, A .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1989, 8 (02) :147-155
[10]  
BOLAND CR, 1984, PROGR CANCER RES THE, V29, P253